Video Module

Multiple Myeloma: Current and Future Perspectives

Source: Highlights of the 12th International Myeloma Workshop: A Video-Based Educational Program*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Multiple Myeloma: Current and Future Perspectives

Faculty:

Paul G. Richardson, MD

CREDIT INFORMATION

Release Date: July 13, 2009

Expiration Date: July 12, 2010

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Analyze the potential of targeting pathways and signaling cascades such as Akt and heat shock protein 90 (Hsp90) for multiple myeloma therapy
Assess Hsp90 inhibition as a potential novel treatment approach for multiple myeloma
Evaluate the role of cytogenetics, proteomic analysis, and FISH analysis in myeloma risk stratification

CCO Video Module contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.